J&J releases promising results from multiple Phase III trials for Darzalex

Home

>

>

>

J&J releases promising results from multiple Phase III trials for Darzalex

February 2025

|

00 issues in this vol.

No items found.

Recent Issues of The Dose

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

FDA introduces new approval framework for rare disease therapies

From pilots to production: AI becomes priority for pharma leaders

Major pharmaceutical manufacturers plan to overcome the patent expiration cliff

Merck presents results across hematology pipeline

Amazon plans to expand reach into generic pharmaceuticals with online pharmacy

FDA approves first new treatment for schizophrenia in decades

Mesopher cell therapy shows 50 increase in 2 year rfs in pancreatic cancer study

Xeureka fortanix and nvidia partner to enhance accuracy of ai powered drug discovery

FDA approves lillys kisunla for early symptomatic alzheimers disease

BMS announces positive results for opdivo and yervoy to treat melanoma

AI-Powered patient education evaluating chatgpt 4 0 as a resource for uveitis

FDA warns of t cell malignancies with car t cell therapies

FDA approves vertexs casgevy for transfusiondependent beta thalassemia (tdt)

Major pharma companies looking to scale back m&a stragegies amid economic downturn

FDA investigation of car-t cell therapies

Biden signs executive order for a.i. safeguards

FDA approves the use of ojjaara (momelotinib) for intermediate/high-risk myelfibrosis in adults

FDA approves biomarin's roctavian, the first gene therapy for adults with severe hemophilia a

Following legal battles with abbvie, humira (adalimumab) biosimilars have launched in the u.s.

Eisai and biogen's alzheimer asset, leqembi, recieves fda full approval

New data demonstrate that carvykti reduces risk of disease progression by 74% in multiple myeloma (mm)

Astellas acquires iveric bio for ~$5.9 b

Pfizer demonstrates committment to oncology with $43 billion acquisition of seagen

Race disparities in breast cancer treatment and adverse effects among non-hispanic women: a comprehensive analysis

There are no available events matching the current filters.

contact_img

contact_img_mob

contact us

Get In Touch With Us

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Stay Informed with the Latest Insights

Get expert analysis, industry trends, and exclusive updates delivered straight to your inbox. Stay ahead of the curve with valuable insights that drive success.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.